acc.21 virtual live sessions...acc.21 virtual brings you access to 50 live education sessions across...

1

#ACC21

Information is current as of May 10, 2021.FEATURED SESSIONSLogin to the ACC.21 virtual platform (https://acc21.virtual-acc.org) to watch more than 100 Featured Sessions On Demand.

SATURDAY, MAY 15 8 – 8:25 A.M. ET 8:25 – 9 A.M. ET 9 – 10:30 A.M. ET 10:30 A.M. – NOON ET 12:15 – 1:45 P.M. ET 2 – 3:30 P.M. ET 3:30 – 4:45 P.M. ET 4:45 – 6 P.M. ET 6 – 7:35 P.M. ET

HOT TOPICS CHANNEL

416. What’s Brewing at ACC.21

401. ACC.21 OpeningShowcase

402. Joint AmericanCollege of Cardiology/Journal of the American College of CardiologyLate-BreakingClinical Trials

616. Controversies in Arrhythmia Therapy: Joint Symposium of the Heart Rhythm Society and the American College of Cardiology

403. Featured Clinical Research I

654. AntithromboticManagementin Patients With Atrial Fibrillation Undergoing PCI

643. The Future of Dyslipidemia Management:Joint Symposium of the National Lipid Association and the American College of Cardiology

619. COVID-19 and Echocardiography— Impact, Imaging, and Innovation: Joint Symposium of the American Society of Echocardiographyand the American College of Cardiology

798. ACC CardiologyHour I

GUIDELINES CHANNEL



603. The Advanced Heart Failure Therapies of LVAD and Transplant: Who, What, When, Where, Why, and How?

51. Intensive Session I: COVID-19 — Uncovering the SilverLinings Featuring the 52nd Annual Louis F. Bishop Keynote

52. Intensive Session II: COVID-19 — Uncovering the Silver Linings

606. Cardiovascular Imaging For Diagnosis And Management of Coronary Microvascular Disease

607. Invasive Imaging and Physiology Diagnosis and Management of ACS Patients and Plaques

801. Core Knowledgein Action: What Everyone Ought To Know About HFpEF

1602. Anti-coagulation Trivia From A to V: Manage-ment Strate-gies Across the Board

INTERDISCIPLINARY EDUCATION CHANNEL



636. Complex Case-Based Decision-Making — The Heart Team in Action: A Joint Symposium by TCT and the American College of Cardiology

609. Caring for the Patient with STEMI in 2021: Comprehensive, Competent and Conscientious Care

626. Nuts & Bolts of Pregnancy and Congenital Heart Disease

634. New and Emerging BreakthroughMedicines for HFrEF! Now What Do We Do?

661. Men Are From Mars, Women Are From Venus: Sex-Specific Risk Factors That Enhance CVD Risk

648. ECGs With the Experts: Practical Considerations For the CV Clinician

GLOBAL CARDIO- VASCULAR HEALTH CHANNEL



610. Pre-operative Care for Non-Cardiac Surgery: Emerging Strategies and Ongoing Controversies

651. What Can We Learn From Each Other For Global Heart Failure Care? A “Global Health Spoken Here” Session

628. Hypertension Guidelines: Do They Vary Across the World as Much as My Blood Pressure Has Today?A “Global Health Spoken Here” Session

645. Cardiac Culture Medium: Current Concepts in Infective EndocarditisA “Global Health Spoken Here” Session

623. Disparities and the Role of Social Determinants of Health in Acute and Stable Ischemic Heart Disease

638. Evolution of Aortic Valve Replacement in Low-Risk Patients

TOPIC ESSENTIALS 1 CHANNEL



625. Controversies in the ICU Management of Congenital Heart Disease

614. Diabesity: A Tale of Obesity, Inflammation and Cardiometabolic Risk

620. Using Physiology and Intravascular Imaging During CHIP PCI: Helpful or Wasteful?

646. Lower Extremity PAD: Diagnostic Dilemmas, Disparities, and Patient Centered Outcomes

602. Left Atrial Appendage Occlusion Clinical Challenges: A Case-Based Approachfrom the Experts

629. Journey of the Right Ventricle in PAH: Staying Alive

1601. Tracking the CV Impact of SGLT2i’s: Practice Essentials




662. Doorways to the Heart: Valves in Systemic Disease

6004. FIT Jeopardy: Battle of the State Chapters Semi-Finals

635. Stress Echo Beyond Obstructive CAD

656. Mitral Valve Interventions:Percutaneous MitralValve Repair

618. Challenging Casesin Cardio-Oncology

655. Bleeding Reduction StrategiesFollowing PCI

https://acc21.virtual-acc.org

#ACC21


SUNDAY, MAY 16 8 – 9:30 A.M. ET 9:30 – 10:45 A.M. ET 10:45 A.M. – 12:15 P.M. ET 12:30 – 1:45 P.M. ET 2 – 3:30 P.M. ET 3:30 – 4:45 P.M. ET 4:45 – 6 P.M. ET 6 – 7:35 P.M. ET

HOT TOPICS CHANNEL

406. Joint American College of Cardiology/Journal of the American Medical Association Late-Breaking Clinical Trials II

707. Beyond Atrial Fibrillation — Atrial Cardiopathy as a Cause of Cryptogenic Stroke: Joint Symposium of the American Heart Association and the American College of Cardiology

407. Joint American College of Cardiology/New England Journal of Medicine Late-BreakingClinical Trials III

699. International Perspectives From the European Society of Cardiology and the American College of Cardiology: The EuropeanHeart Journal’s Year in Cardiovascular Medicine

409. Featured Clinical Research II

725. Cardiac CT in Clinical Practice: Joint Symposium of the Society of Cardiovascular Computed Tomography and the American College of Cardiology

721. Universal Definition of Heart Failure: Joint Symposium of the Heart Failure Society of American and the American College of Cardiology

799. ACC Cardiology Hour II

GUIDELINES CHANNEL

802. Core Knowledge in Action: Return to the Basics of Aortic Stenosis

686. Venous Thromboembolism:Current Controversies andPractical Management

803. Core Knowledge in Action: The Ultimate Guide to Lipids

696. Repair is not Correction: Long Term Follow-up of Surgery For Congenital Heart Disease

694. Current Approaches to Antiplatelet Therapy For PCI in Acute Coronary Syndrome

720. New AHA/ACC Valve Guidelines: A Paradigm Shift in Management of Severe Aortic Stenosis

732. Applying the Guidelines For Lipid Management in Special Populations

1605. The Evolving Lipids Landscape: Current and Emerging Nonstatins


102. Pharmacology I: Expanding the CardiovascularPharmacology Toolbox — Improving Outcomes One Medication at a Time

104. Pharmacology II:Tackling the Supersized Epidemic of Cardio-diabetes

105. Pharmacology III: An Ounce of Prevention is Worth a Pound of Cure — Advances in Cardio-Oncology

701. PharmacotherapyConsiderations in Cardio-Obstetrics

673. Drug Jeopardy: PharmacologicalConundrums in ArrhythmiaManagement

727. Cardiogenic Shock:Teams and Devices for Cardiogenic Shock

729. The TeleHealth Cardiac Team: Challenges and Opportunities


734. Vascular Manifestations of COVID-19 Around the GlobeA “Global Health Spoken Here” Session

663. Minimally Invasive Therapies and Devices in AHF Featuring the 2021 Douglas Zipes Award Keynote

683. Perspectives on Pulmonary HypertensionA “Global Health Spoken Here” Session

690. Cardiac Point of Care Ultrasound Around the World A “Global Health Spoken Here” Session

679. Right Sided Valve Interventions

703. The Constant Debate TAVR Versus SAVR — One Size Does Not Fit All: Joint Symposium of the Society of Thoracic Surgeons and the American College of Cardiology

717. Working Together to Improve Pediatric and Congenital Heart Disease Care Around the World A “Global Health Spoken Here” Session

789. Global Burden of Cardiovascular Disease in Women: Report of The Lancet Commission


901. Highlighted Original Research Topic Essentials 1: Arrhythmias and Clinical EP and the Year in Review

904. Highlighted OriginalResearch: Pulmonary Hypertension and the Year in Review

902. Highlighted Original Research: Heart Failure and Cardiomyopathies and the Year in Review

903. Highlighted Original Research: Interventional Cardiology and the Year in Review

905. Highlighted Original Research: Vascular Medicine and the Year in Review

6005. FIT Jeopardy: Battle of the State Chapters Finals

408. Late-BreakingClinical Trials Deep Dive Session I

1604. What’s New in HF Pharmacotherapies: The What, How, and Wow


669. Management of Pediatric Cardiology and Cardiac Surgery in the Post-COVID World: Where do we go from here? Featuring the Dan G. McNamara Keynote

624. How to Stent a LM Like a Boss: Left Main PCI Workshop

678. Complex and High-Risk PCI: Case Based Joint Symposium by the Society of Cardiovascular Angiography and Interventions and the American College of Cardiology

674. Clarity From Confusion in Heart Failure With Preserved Ejection Fraction (HFpEF) Featuring the Kanu and Docey Chatterjee Keynote

711. Top Indications for Cardiovascular Magnetic Resonance in Modern Cardiology: Case-Based Joint Symposium of the Society for CardiovascularMagnetic Resonance and the American College of Cardiology

708. Unmasking the Effect of COVID-19 on Heart Failure in Diverse Populations: Joint Symposium of the Association of Black Cardiologists and the American College of Cardiology

693. Parenteral Antithrombotic Therapies for ACS and PCI

2


3

#ACC21


MONDAY, MAY 17 8 – 9:30 A.M. ET 9:30 – 10:45 A.M. ET 10:45 A.M. – 12:15 P.M. ET 12:30 – 1:45 P.M. ET 2 – 3:30 P.M. ET 3:30 – 4:30 P.M. ET

HOT TOPICS CHANNEL

410. Late-BreakingClinical Trials IV

759. International Perspectives From the European Societyof Cardiology II and American College of Cardiology

411. Late-BreakingClinical Trials V

412. Featured ClinicalResearch III

414. Late-Breaking Clinical Trials Deep Dive II

800. ACC CardiologyHour III

GUIDELINES CHANNEL

804. Core Knowledge in Action: Essentials of Atrial Fibrillation Management — Learn From the Experts

766. Imaging Decision Making in Everyday Clinical Practice For Coronary Artery Disease

781. Cardiologist Versus Calcium: Unstoppable Force MeetsImmovable Object

805. Core Knowledgein Action: Essentials of Stable Ischemic Heart Disease

747. Updates in Managementof Hypertrophic Cardiomyopathy


737. Hemodynamics of Heart Failure: You Thought You Knew Them

744. Topical Topics in Pulmonary Hypertension

748. Cardio-Oncology:Today’s Standard of Practice

770. Great Debates in Vascular Medicine

780. CardiovascularImaging to Enhance Prevention


913. World Heart Federation Featured Research With Year in Review A “Global Health Spoken Here” Session

746. How to Choose and Optimize Pacing in Patients with Heart Failure: Conduction System Pacing and CRT

745. The Time Has Come For Systematic Screening For Asymptomatic Atrial FibrillationA “Global Health Spoken Here” Session

769. Advancing Systems of Care in STEMI, Stroke, Cardiac Arrest, Shock A “Global Health Spoken Here” Session

782. Aortic Valve Interventions:Clinical Dilemmas A “Global Health Spoken Here” Session


912. Highlighted Original Research: Prevention and the Year in Review

908. Highlighted Original Research: NonInvasive Imaging and the Year in Review

914. Highlighted Original Research: Valvular Heart Disease and the Year in Review

413. Best of JACCJournals & Eugene Braunwald Keynote

787. Vasculo-Oncology:Lessons Learned For Clinical Practice in 2021


911. Highlighted Original Research: Pediatric and Congenital Heart Disease and the Year in Review

910. Highlighted Original Research: Acuteand Stable Ischemic Heart Disease and the Year in Review

739. Advanced Nuclear Cardiology Applications in 2021: Joint Symposium of the American Society of Nuclear Cardiology and the American College of Cardiology

777. Contemporary Aortic Valve Disease Management: Joint Symposium of the American Association For Thoracic Surgery and the American College of Cardiology

774. Let’s Get Physical! Exercise and Cardiovascular Health


4

#ACC21

Information is current as of May 10, 2021.PATHWAY COLLECTIONSLogin to the ACC.21 virtual platform (https://acc21.virtual-acc.org) to sample from an unparalleled array of education across 11 learning pathways covering the full spectrum of cardiology when it’s convenient for you — from your home, office, or on-the-go.

ELECTRO- PHYSIOLOGY

601. Arrhythmogenic Cardiomyopathies: Tell MeWhat I Need to Know?

631. Use of Direct Oral Anticoagulants in SpecialPopulations: Complex Dosing Strategies and Complicated Patients

632. EP Issues in Cancer Patients — Beyond Heart Failure

647. Atrial Fibrillation Management in Athletes

648. ECGs With the Experts: Practical Considerations For the Cardiovascular Clinician

687. Managing the Device Patient in 2021: From Cybersecurity to MRI and Beyond

705. Proarrhythmia “Look Outs!” From the ICU to the Food We Eat

706. Reversible Cardiomyopathies:Arrhythmias, Pacing,Dyssynchrony and Inflammation

736. Sex Differences in Arrhythmias

762. Mobile ECG Monitoring: How Can WeUtilize Wearable Data

763. Virtual Outpatient Experience For CardiacElectrophysiologists:High Yield Topics

778. Star Wars: What Does the Future Hold For EP?

HEART FAILURE AND CARDIO- MYOPATHIES

604. Treating Comorbidities to Treat Heart Failure: Sleep, Exercise, Weight Loss, Iron, and More!

617. Unfolding the Mysteries of Cardiac Amyloidosis: An Interactive Case-Based Town Hall Discussion

633. Diabetes andHeart Failure

649. Holy Estrogen! Sex Disparities in Heart Failure Therapies: Biology, Bias or Both?

650. Contemporary Challenges in Cardiac Critical Care: Structure, Staffing, Training, and Beyond

651. What Can We Learn From Each Other For Global Heart Failure Care? A “Global Health Spoken Here” Session

675. Harnessing the Power of Technology: Remote Monitoring andManagement in HF

688. Treat the Pump or Treat the Rhythm? Let’s Talk About Both!

689. Destined to Fail? How to Prevent Heart Failure

709. Controversial Topics in Cardiac Transplantation and Ventricular Assist Devices

722. Myocarditis and Heart Failure

723. Off-Beat Topics in Heart Failure: Improving Dysfunction By Treating the Rhythm

738. COVID-19 and Heart Failure: Lessons Learned and Future Directions

749. Overcoming Therapeutic Inertia- Maximizing Guideline Driven Medical Therapy in Heart Failure

764. To Right a Wrong in Heart Failure

765. Precision in Classification and Treatment of Heart Failure: One Size Does Not Fit All

779. When Fat Overpowers Muscle:Obesity and the HFpEF Epidemic

INTERVENTIONAL AND STRUCTURAL

201. Interventional Live Cases I: Transmission FromOhioHealth Riverside

202. Interventional Live Cases II:Transmission From OhioHealth Riverside

203. Interventional Live Cases III: Transmission From The Miriam Hospitalin Providence, RI

204. Interventional Live Cases IV: Transmission From The Miriam Hospitalin Providence, RI

608. Precision PCI in the Real World: What Do I Use Every Day?

621. Endovascular Skills: Basics to Bailout Techniques

622. Case-Based Learning For the Cardiovascular Team

637. Imagination is Everything: Innovations in the Cath Lab

654. Antithrombotic Management in Patients With Atrial Fibrillation Undergoing PCI

655. Bleeding ReductionStrategies Following PCI

656. Mitral Valve Interventions:Percutaneous MitralValve Repair

665. AntithromboticControversies in the Cath Lab

666. Shock Teams and Shock Docs

692. Fellows Bootcamp:Structural

713. Fellows Bootcamp: Coronary and PeripheralDisease Management — The Best Cases You Have Seen Yet!

712. Your PVI Toolkit

714. Aortic Valve Interventions:Expanding Indications

726. 2020 Clinical Trials ThunderDome: Who Will Be Crowned “Most Impactful”?

728. Expanding Frontiersin Vascular Intervention

740. Complex Dilemmas in Valvular Heart Disease

741. Tough Choices: Cases in Cardiogenic Shock

752. Transcatheter MitralValve Replacement: Expanding Indications and Trial Updates

753. How to Deal With Cases That Go From “No Problem” to Nightmare

754. Debates: Should We Tailor Antiplatelet Therapy For PCI?

768. Venous Interventions 2021

771. Under the Bright Light: Debates in Interventional Cardiology

906. Interventional Challenging Cases I:Will Make You Think!

909. Interventional Challenging Cases II: An Interventional & SHD Potpourri Not to Miss!


5

#ACC21

Information is current as of May 10, 2021.PATHWAY COLLECTIONS

Login to the ACC.21 virtual platform (https://acc21.virtual-acc.org) to sample from an unparalleled array of education across 11 learning pathways covering the full spectrum of cardiology when it’s convenient for you — from your home, office, or on-the-go

ISCHEMIC HEART DISEASE

611. Cardiogenic Shock: Progress, Paradigms, andUnresolved Problems

639. Pharmacologic and Lifestyle Management For ISHD: Why Disparities in Care Matter

640. Critical Clinical Conundrums in Acute Coronary Syndromes

657. Sticky Situations For Revascularization in SIHD: When the Evidence Is Limited but Opinions Are Vast

658. Diagnostic Testing in Stable Ischemic Heart Disease: Choosing Wisely Room

667. Recent Trials in SIHD: Translating Results into Clinical Practice?

668. Chest Pain Evaluation in 2021: Same Problem, New Tools, New Questions

680. Debating Controversies inSTEMI Care

681. Gender-Specific Care of Patients With Acute Coronary Syndrome

695. What’s In a Name? Practicalities of the 4th Universal Definition of MI

716. Cardiac Rehab:Move to Improve!

730. Dissecting the Data: Discussions on the Management of SCAD

742. MINOCA: A Show and Tell With the Experts

755. ASCVD Risk Factors and Beyond

783. Lessons From COVID in Racial/Ethnic Disparities: Implications For CV Prevention and Care

784. Yes, No, Maybe: How to Diagnose and Treat INOCA (Ischemiaand No Obstructive Coronary Artery Disease) Today

MULTIMODALITY IMAGING

605. Registries in CardiacImaging: How Will They Change Clinical Practice?

652. Multimodality Imaging in ChallengingCases of Infective Endocarditis

653. Best Practices of Multimodality Imagingin Percutaneous Mitral Interventions

664. Multimodality Cardiac Imaging andModern Media

676. MultimodalityImaging in Cardio-Oncology

677. Current Controversies and Debates in CAD Imaging

691. Imaging Cardiomyopathies:Challenging Cases

710. Multimodality Imaging of Athletes: What Do the New Consensus Statement Teach Us?

724. Cardiac Imaging in Older Adults: Overused orUnderutilized? Practical Points for Clinician

750. Role of MultimodalityImaging in Diagnosis and Management of Cardiovascular Complications in Patients With COVID-19

751. How Can I Tell If This Aortic Valve Replacement Is Functioning Normally?

767. New Innovations in Cardiovascular Imaging - IncorporatingArtificial Intelligence Into Daily Practice

PEDIATRIC AND CONGENITAL HEART DISEASE

612. Adult Congenital Heart Disease Cases That Stumped Me

641. Imaging of Congenital Heart Disease: Seeing ThingsWe Never Saw Before

659. Heterotaxy Syndrome or Somerism: Whose “Side” Are You On?

682. Non-Clinical Education that ChangedMy Life — A Pecha Kucha Primer

731. Debates in Arrhythmia Managementin Congenital Heart Disease

756. Lifelong Impact of Cardiovascular Risk Factors in Patients with Congenital Heart Disease

772. Challenges of Transplantation in Congenital Heart Disease Patients: Ethics, Listing Strategy & MCS

785. Controversies in Interventional and Surgical Management of Congenital Heart Disease

PREVENTION AND HEALTH PROMOTION

613. I Know the Evidence: So How Do I Incorporate Nutrition and Lifestyle in My Clinic?

627. Innovative Nutritional and Dietary Approaches For Cardiometabolic Disease

642. G&G: Genetics through Geriatrics — CV Prevention Through the Lifespan

660. Cardiovascular Considerations in Amateurand Professional Athletes

670. Expanding the Toolkit: Tackling ResidualAtherogenic Lipid Risk

697. From Controversy to Clarity in Weight Loss Therapies

718. Hypertension Management: A FutureFull of Promises?

719. Getting to the Root of Dietary Effects

743. Getting Your Life-and-Style Back in CVD

757. CVD Prevention in the Post-COVID19 Era

758. Vulnerable Plaques: Intervention or Pharmacologic Therapy

773. Tackling Cardiometabolic Risk: A Case-Based Discussion

PULMONARY VASCULAR DISEASE

644. Polite Parlays in Pulmonary Hypertension

698. Pulmonary Hypertension Primer: WHO Are the Groups?

775. Progression of Pulmonary Arterial HypertensionPharmacotherapy:Plainly Played-out in a Patient Case


6

#ACC21

Information is current as of May 10, 2021.PATHWAY COLLECTIONS

Login to the ACC.21 virtual platform (https://acc21.virtual-acc.org) to sample from an unparalleled array of education across 11 learning pathways covering the full spectrum of cardiology when it’s convenient for you — from your home, office, or on-the-go

SPECIAL TOPICS

404. Cases From the Guidelines For Clinicians

615. How Much is Too Much? Navigating Medication Overload by Medication Deprescribing

671. International Center of Excellence

685. Obstructive Sleep Apnea and Cardiovascular Outcomes:What do Cardiologists Need to Know?

700. Clinical TrialsResearch: Upping Your Game

760. Return To Play: What The Experts Would Do

788. Professionalism andEthics in Cardiology

907. FIT Forum: Stump the Professor

101. Cardiovascular Update For the Clinician I: A Symposium by Valentin FusterCoronary Artery Disease — Atherogenesis, Acute Coronary Syndromes and Stroke

103. Cardiovascular Update For the Clinician II: A Symposium by Valentin FusterFour Models of Myocardial Disease and Heart Failure — Myocarditis, HFrEF, HFpEF, HCM

106. Cardiovascular Update For the Clinician IIIElectrical Disorders — Rhythm and Conduction Disorders

107. Cardiovascular Update For the Clinician IVStructural Heart Disease Challenges in 2021 — Aortic, Mitral and Tricuspid Diseases, Hypertrophic Cardiomyopathies

630. Women CAN Afford to Stay in Academic Medicine: WICLunchtime Symposium

790. Fireside Panel: Is the Quality of Cardiovascular Research Declining? What Research Should Continue to be Pursued

791. Must Know Tips for Publishing in JACC Journals

792. How to Become a Successful Researcher at Every Stage of Your Career

793. Fireside Panel: How to be an Effective Mentor and Mentee

794. JACC: Case Reports:Focus on Interventional Complications

795. JACC: Case Reports: Da Vinci Corner: Translational Cardiac Anatomy 101

796. JACC: Case Reports:Rapid Fire Session on Valvular Heart Disease

797. JACC: Case Reports: StructuralComplications and Howto Deal With Them

915. Young Investigator Awards: Basic and Translational Science

916. Young Investigator Awards: Clinical Investigations

917. Young Investigator Awards: Outcomes Research

6502. The Evolving Role of the Advance Practice Providers in Cardiovascular Medicine

6505. Challenges in Peer Review and Journal Publishing: COVID-19, Preprint, Open Access, Quality, and the Quest for First and Faster

6507. How Are Members Doing?

6508. Art with Heart: Tales of Creativity in Cardiology

6509. Is the Collaborative Maintenance Pathway (CMP) the MOC Assessment Option for You? Hear From Your Colleagues Who Took the CMP in 2020

6510. Social Media for Cardiologists: Why, When, How, and Where

6511. Getting to the Heart of Costs and Quality: Global Perspectives on Value-based Care

6512. Achieving Gender Equity in Cardiology

6513. ACC Strategic Global Initiative

VALVULAR HEART DISEASE

672. Mitral Valve Diseaseand Cardiac Arrest: Innocent Bystander or Guilty As Charged?

684. Tricuspid Regurgitation: No Longer the “Forgotten” Valve

702. Uniquely Bicuspid Valve: Two Leaflet and a Tool Kit

733. The Ebb and Flow: A ContemporaryUnderstanding of the Diagnosis and Management of Low Flow Low Gradient Severe Aortic Stenosis

761. Indirect Vavlular Heart Disease: Problems and Perspectives

776. Valvular Conundrums: Grey Area Cases, What the Experts Think

786. A Melting Pot of Clinical Vavular Heart Disease Cases: No Cookbook, but a PracticalApplications From the Valve Guidelines

VASCULAR MEDICINE

704. Emerging Technologies in Vascular Disease

735. Essential Vascular Pearls for the Cardiovascular Clinician


7

#ACC21

Information is current as of May 20, 2021.LEARNING DESTINATIONS

* Learning Destinations presentations are not part of ACC.21, as planned by its Program Committee, and do not qualify for continuing medical education (CME), continuing nursing education (CNE), or continuing education (CE) credit.

ACC’s signature Learning Destinations offers diverse, non-certified* education that will provide insights into burgeoning cardiovascular innovations during 30-minute Innovation Stage sessions or 60-minute Industry-Expert Theater sessions. Click on the session titles below to watch the sessions (you must be logged into the virtual platform: https://acc21.virtual-acc.org) and learn from industry leaders as they share the latest in cardiovascular practices, services, and technologies.

INDUSTRY-EXPERT THEATER

4001. Help Your Recent MI Patients Achieve Lower LDL-C and Reduce the Risk of Another MI

Sponsored by Amgen

4002. VASCEPA® (icosapent ethyl): Elevating the Standard of Care

Sponsored by Amarin Pharma, Inc.

4004. Understanding the Impact of Lp(a) in ASCVD: A Focus on Added CV Risk, Guidelines and Testing

Sponsored by Amgen

4007. Cross-Sector Perspectives on Diversity, Equity, and Inclusion: Opportunities to Strengthen the Cardiovascular Field Together

An ACC driven program with sponsor support from Amgen, AZ and BMS

4008. Potential Mechanisms Responsible for the Effects of Incretins on Atherosclerosis

Sponsored by Lilly

4009. Advances and New Studies for the Treatment of MR With Abbott’s TMV Repair and Replacement Therapies

Sponsored by Abbott

4010. Left Ventricular Ejection Fraction: Past, Present, and Future Role in Heart Failure Care

Novartis Pharmaceuticals Corporation - Medical Affairs

4011. Practical Pearls on ASCVD and Lipid Management

Novartis Pharmaceuticals Corporation - Medical Affairs

4012. Thrombosis & Prevention in COVID-19: What Are We Missing?

Sponsored by CPC Clinical Research

4014. How Does Paradise Renal Denervation Fit Into Hypertension Treatment Management?

Sponsored by ReCor Medical

4015. A Review of the RADIANCE-HTN Global Clinical Trial Program: A Focus on the TRIO cohort

Sponsored by ReCor Medical

4016. Advancing Patient Care Across the Heart Failure Continuum

Sponsored by Abbott

4017. Re-imagining the 90-Day High-Risk Period Post-AMI: Expert Discussions on Cholesterol Efflux and ApoA-I in Plaque Stabilization

Sponsored by CSL Behring LLC

4018. Beyond a Broken Heart: Multisystem Disease Burden in hATTR Amyloidosis

Sponsored by Alnylam Pharmaceuticals

4019. Strategies for Bleeding Avoidance After Complex PCI

Sponsored by Medtronic

4020. Implementing Rhythm Control Guidelines in Atrial Fibrillation: The Good, The Bad, and The Ugly

Sponsored by Sanofi

4021. Managing Today’s Advanced Heart Failure Patient

Sponsored by Cytokinetics

4022. A Practical Approach to Shared Decision Making When Treating Heart Valve Disease


4023. Streamlining Diagnosis and Treatment in Chronic Coronary Artery Disease

Sponsored by GE Healthcare

4024. Coronary IVL’s Who, What, Where, When & Why: An Introductory Guide for Clinical Practice

Sponsored by Shockwave Medical

4025. Hemodynamics: New Recommendations on How to Monitor Patients Post TAVR/SAVR

Sponsored by Edwards Lifesciences

4027. CCM® Therapy – A Device Based Approach for the Treatment of Heart Failure

Sponsored by Impulse Dynamics

4029. Raising the Clinical Suspicion for Hypertrophic Cardiomyopathy

Sponsored by Bristol Myers Squibb

4030. Stroke Prophylaxis: Treating the Untreated

Sponsored by Boston Scientific

4031. What You Don’t Know Can’t Help Them – Remote Management of Patients Using Wearables

Sponsored by ZOLL

4033. Protected PCI: Diagnosis and Treatment of High-Risk and Complex Coronary Disease for Superior Long-term Outcomes

Sponsored by Abiomed

4036. International Centers of Excellence: Todays Solutions for an Improved Tomorrow

Sponsored by ACC’s Global Quality Solutions

4042. ACC.21 Highlights in Hypertension 4043. New Hypertension Therapies in Asian People

4044. The US-China Consensus on High Efficiency PVI Using RF Energy in Patients With Paroxysmal AF and AF Workflow Sharing

Sponsored by Biosense Webster

https://acc21.virtual-acc.orghttps://acc21.virtual-acc.org/ondemand/?sid=2373https://acc21.virtual-acc.org/ondemand/?sid=2373https://acc21.virtual-acc.org/ondemand/?sid=2373https://acc21.virtual-acc.org/ondemand/?sid=2373https://acc21.virtual-acc.org/ondemand/?sid=2373https://acc21.virtual-acc.org/ondemand/?sid=2416https://acc21.virtual-acc.org/ondemand/?sid=2416https://acc21.virtual-acc.org/ondemand/?sid=2416https://acc21.virtual-acc.org/ondemand/?sid=2416https://acc21.virtual-acc.org/ondemand/?sid=2374https://acc21.virtual-acc.org/ondemand/?sid=2374https://acc21.virtual-acc.org/ondemand/?sid=2374https://acc21.virtual-acc.org/ondemand/?sid=2374https://acc21.virtual-acc.org/ondemand/?sid=2374https://acc21.virtual-acc.org/ondemand/?sid=2443https://acc21.virtual-acc.org/ondemand/?sid=2443https://acc21.virtual-acc.org/ondemand/?sid=2443https://acc21.virtual-acc.org/ondemand/?sid=2443https://acc21.virtual-acc.org/ondemand/?sid=2443https://acc21.virtual-acc.org/ondemand/?sid=2443https://acc21.virtual-acc.org/ondemand/?sid=2443https://acc21.virtual-acc.org/ondemand/?sid=2417https://acc21.virtual-acc.org/ondemand/?sid=2417https://acc21.virtual-acc.org/ondemand/?sid=2417https://acc21.virtual-acc.org/ondemand/?sid=2372https://acc21.virtual-acc.org/ondemand/?sid=2372https://acc21.virtual-acc.org/ondemand/?sid=2372https://acc21.virtual-acc.org/ondemand/?sid=2372https://acc21.virtual-acc.org/ondemand/?sid=2372https://acc21.virtual-acc.org/ondemand/?sid=2418https://acc21.virtual-acc.org/ondemand/?sid=2418https://acc21.virtual-acc.org/ondemand/?sid=2418https://acc21.virtual-acc.org/ondemand/?sid=2418https://acc21.virtual-acc.org/ondemand/?sid=2419https://acc21.virtual-acc.org/ondemand/?sid=2419https://acc21.virtual-acc.org/ondemand/?sid=2419https://acc21.virtual-acc.org/ondemand/?sid=2429https://acc21.virtual-acc.org/ondemand/?sid=2429https://acc21.virtual-acc.org/ondemand/?sid=2429https://acc21.virtual-acc.org/ondemand/?sid=2429https://acc21.virtual-acc.org/ondemand/?sid=2377https://acc21.virtual-acc.org/ondemand/?sid=2377https://acc21.virtual-acc.org/ondemand/?sid=2377https://acc21.virtual-acc.org/ondemand/?sid=2377https://acc21.virtual-acc.org/ondemand/?sid=2377https://acc21.virtual-acc.org/ondemand/?sid=2378https://acc21.virtual-acc.org/ondemand/?sid=2378https://acc21.virtual-acc.org/ondemand/?sid=2378https://acc21.virtual-acc.org/ondemand/?sid=2378https://acc21.virtual-acc.org/ondemand/?sid=2378https://acc21.virtual-acc.org/ondemand/?sid=2380https://acc21.virtual-acc.org/ondemand/?sid=2380https://acc21.virtual-acc.org/ondemand/?sid=2380https://acc21.virtual-acc.org/ondemand/?sid=2380https://acc21.virtual-acc.org/ondemand/?sid=2421https://acc21.virtual-acc.org/ondemand/?sid=2421https://acc21.virtual-acc.org/ondemand/?sid=2421https://acc21.virtual-acc.org/ondemand/?sid=2421https://acc21.virtual-acc.org/ondemand/?sid=2421https://acc21.virtual-acc.org/ondemand/?sid=2421https://acc21.virtual-acc.org/ondemand/?sid=2381https://acc21.virtual-acc.org/ondemand/?sid=2381https://acc21.virtual-acc.org/ondemand/?sid=2381https://acc21.virtual-acc.org/ondemand/?sid=2381https://acc21.virtual-acc.org/ondemand/?sid=2382https://acc21.virtual-acc.org/ondemand/?sid=2382https://acc21.virtual-acc.org/ondemand/?sid=2382https://acc21.virtual-acc.org/ondemand/?sid=2382https://event.arraylive.com/arraylearn/virtual-client-app/#/?session=313723_01https://event.arraylive.com/arraylearn/virtual-client-app/#/?session=313723_01https://event.arraylive.com/arraylearn/virtual-client-app/#/?session=313723_01https://event.arraylive.com/arraylearn/virtual-client-app/#/?session=313723_01https://event.arraylive.com/arraylearn/virtual-client-app/#/?session=313723_01https://acc21.virtual-acc.org/ondemand/?sid=2386https://acc21.virtual-acc.org/ondemand/?sid=2386https://acc21.virtual-acc.org/ondemand/?sid=2386https://acc21.virtual-acc.org/ondemand/?sid=2386https://acc21.virtual-acc.org/ondemand/?sid=2385https://acc21.virtual-acc.org/ondemand/?sid=2385https://acc21.virtual-acc.org/ondemand/?sid=2385https://acc21.virtual-acc.org/ondemand/?sid=2385https://acc21.virtual-acc.org/ondemand/?sid=2385https://acc21.virtual-acc.org/ondemand/?sid=2422https://acc21.virtual-acc.org/ondemand/?sid=2422https://acc21.virtual-acc.org/ondemand/?sid=2422https://acc21.virtual-acc.org/ondemand/?sid=2422https://acc21.virtual-acc.org/ondemand/?sid=2387https://acc21.virtual-acc.org/ondemand/?sid=2387https://acc21.virtual-acc.org/ondemand/?sid=2387https://acc21.virtual-acc.org/ondemand/?sid=2387https://acc21.virtual-acc.org/ondemand/?sid=2387https://acc21.virtual-acc.org/ondemand/?sid=2413https://acc21.virtual-acc.org/ondemand/?sid=2413https://acc21.virtual-acc.org/ondemand/?sid=2413https://acc21.virtual-acc.org/ondemand/?sid=2413https://acc21.virtual-acc.org/ondemand/?sid=2413https://acc21.virtual-acc.org/ondemand/?sid=2415https://acc21.virtual-acc.org/ondemand/?sid=2415https://acc21.virtual-acc.org/ondemand/?sid=2415https://acc21.virtual-acc.org/ondemand/?sid=2415https://acc21.virtual-acc.org/ondemand/?sid=2442https://acc21.virtual-acc.org/ondemand/?sid=2442https://acc21.virtual-acc.org/ondemand/?sid=2442https://acc21.virtual-acc.org/ondemand/?sid=2442https://acc21.virtual-acc.org/ondemand/?sid=2388https://acc21.virtual-acc.org/ondemand/?sid=2388https://acc21.virtual-acc.org/ondemand/?sid=2388https://acc21.virtual-acc.org/ondemand/?sid=2388https://acc21.virtual-acc.org/ondemand/?sid=2426https://acc21.virtual-acc.org/ondemand/?sid=2426https://acc21.virtual-acc.org/ondemand/?sid=2426https://acc21.virtual-acc.org/ondemand/?sid=2426https://acc21.virtual-acc.org/ondemand/?sid=2426https://acc21.virtual-acc.org/ondemand/?sid=2379https://acc21.virtual-acc.org/ondemand/?sid=2379https://acc21.virtual-acc.org/ondemand/?sid=2379https://acc21.virtual-acc.org/ondemand/?sid=2379https://acc21.virtual-acc.org/ondemand/?sid=2379https://acc21.virtual-acc.org/ondemand/?sid=2379https://acc21.virtual-acc.org/ondemand/?sid=2414https://acc21.virtual-acc.org/ondemand/?sid=2414https://acc21.virtual-acc.org/ondemand/?sid=2414https://acc21.virtual-acc.org/ondemand/?sid=2414https://acc21.virtual-acc.org/ondemand/?sid=2430https://acc21.virtual-acc.org/ondemand/?sid=2432https://acc21.virtual-acc.org/ondemand/?sid=2432https://acc21.virtual-acc.org/ondemand/?sid=2434https://acc21.virtual-acc.org/ondemand/?sid=2434https://acc21.virtual-acc.org/ondemand/?sid=2434https://acc21.virtual-acc.org/ondemand/?sid=2434https://acc21.virtual-acc.org/ondemand/?sid=2434https://acc21.virtual-acc.org/ondemand/?sid=2434

8

#ACC21

Information is current as of May 20, 2021.LEARNING DESTINATIONS

* Learning Destinations presentations are not part of ACC.21, as planned by its Program Committee, and do not qualify for continuing medical education (CME), continuing nursing education (CNE), or continuing education (CE) credit.

INNOVATION STAGE

4201. Image Guidance and Robotic Automation for Precise Treatment

Sponsored by Siemens Healthineers

4205. Application of Dual Source CT in Cardiac Imaging — A Focus on Structural Heart Disease


4207. Exploring New Synergies: Integrating a Cardiac CT Scanner and Interventional C-arm in our Cath Lab

Sponsored by Canon Medical Systems

4208. Living in 3D


4209. Breakthrough Transcatheter Pulmonary Valve Treatment Option for Adult and Pediatric CHD Patients


4210. PCI in Patients With CKD: Insights From a Nephrology and Interventional Cardiology Partnership

Sponsored by Philips North America LLC

4211. Fusion Imaging for Transcatheter Edge-to-Edge Mitral Valve Repair

Sponsored by Philips North America LLC

https://acc21.virtual-acc.org/ondemand/?sid=2411https://acc21.virtual-acc.org/ondemand/?sid=2411https://acc21.virtual-acc.org/ondemand/?sid=2411https://acc21.virtual-acc.org/ondemand/?sid=2411https://acc21.virtual-acc.org/ondemand/?sid=2424https://acc21.virtual-acc.org/ondemand/?sid=2424https://acc21.virtual-acc.org/ondemand/?sid=2424https://acc21.virtual-acc.org/ondemand/?sid=2424https://acc21.virtual-acc.org/ondemand/?sid=2424https://acc21.virtual-acc.org/ondemand/?sid=2408https://acc21.virtual-acc.org/ondemand/?sid=2408https://acc21.virtual-acc.org/ondemand/?sid=2408https://acc21.virtual-acc.org/ondemand/?sid=2408https://acc21.virtual-acc.org/ondemand/?sid=2408https://acc21.virtual-acc.org/ondemand/?sid=2425https://acc21.virtual-acc.org/ondemand/?sid=2425https://acc21.virtual-acc.org/ondemand/?sid=2425https://acc21.virtual-acc.org/ondemand/?sid=2412https://acc21.virtual-acc.org/ondemand/?sid=2412https://acc21.virtual-acc.org/ondemand/?sid=2412https://acc21.virtual-acc.org/ondemand/?sid=2412https://acc21.virtual-acc.org/ondemand/?sid=2412https://acc21.virtual-acc.org/ondemand/?sid=2390https://acc21.virtual-acc.org/ondemand/?sid=2390https://acc21.virtual-acc.org/ondemand/?sid=2390https://acc21.virtual-acc.org/ondemand/?sid=2390https://acc21.virtual-acc.org/ondemand/?sid=2390https://acc21.virtual-acc.org/ondemand/?sid=2391https://acc21.virtual-acc.org/ondemand/?sid=2391https://acc21.virtual-acc.org/ondemand/?sid=2391https://acc21.virtual-acc.org/ondemand/?sid=2391

acc.21 virtual live sessions...acc.21 virtual brings you access to 50 live education sessions across...

Documents